Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024

BUY
$93.6 - $388.02 $50,918 - $211,082
544 Added 84.6%
1,187 $120,000
Q4 2023

Mar 15, 2024

SELL
$306.88 - $380.0 $166,942 - $206,720
-544 Reduced 45.83%
643 $243,000
Q3 2023

Dec 01, 2023

SELL
$315.92 - $397.36 $220,828 - $277,754
-699 Reduced 37.06%
1,187 $377,000
Q2 2023

Jul 27, 2023

BUY
$346.15 - $392.09 $404,995 - $458,745
1,170 Added 163.41%
1,886 $723,000
Q1 2023

May 17, 2023

BUY
$323.56 - $373.36 $15,207 - $17,547
47 Added 7.03%
716 $267,000
Q4 2022

Feb 21, 2023

BUY
$248.67 - $334.17 $166,360 - $223,559
669 New
669 $221,000
Q2 2022

Aug 12, 2022

SELL
$301.4 - $428.42 $156,125 - $221,921
-518 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$379.46 - $424.54 $196,560 - $219,911
518 New
518 $217,000
Q2 2021

Aug 10, 2021

SELL
$372.36 - $412.07 $215,224 - $238,176
-578 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$357.26 - $392.57 $206,496 - $226,905
578 New
578 $223,000
Q4 2019

Feb 10, 2020

SELL
$281.18 - $322.05 $359,629 - $411,901
-1,279 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$294.25 - $341.49 $120,936 - $140,352
-411 Reduced 24.32%
1,279 $381,000
Q2 2019

Aug 05, 2019

BUY
$279.29 - $336.89 $151,095 - $182,257
541 Added 47.08%
1,690 $570,000
Q1 2019

May 08, 2019

BUY
$246.18 - $297.25 $282,860 - $341,540
1,149 New
1,149 $341,000
Q2 2018

Oct 05, 2018

SELL
$217.98 - $237.23 $272,257 - $296,300
-1,249 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$218.74 - $251.43 $12,249 - $14,080
-56 Reduced 4.29%
1,249 $286,000
Q4 2017

Feb 15, 2018

SELL
$217.88 - $244.43 $217 - $244
-1 Reduced 0.08%
1,305 $285,000
Q3 2017

Nov 13, 2017

SELL
$231.6 - $253.39 $13,201 - $14,443
-57 Reduced 4.18%
1,306 $311,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,363
1,363 $327,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.61B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.